Irache Visiers Guelbenzu

Irache Visiers Guelbenzu is an accomplished executive with extensive experience in regulatory affairs within the biopharmaceutical industry. Currently serving as Vice President and Head of Regulatory Affairs at SpringWorks Therapeutics since November 2023, Visiers Guelbenzu previously held the role of Vice President of Regulatory Affairs at Ribon Therapeutics from May 2022 to October 2023 and Vice President of Global Regulatory Affairs at Black Diamond Therapeutics between February 2021 and May 2022. Earlier career positions include Senior Director and Team Lead of Global Regulatory Affairs for Immuno-Oncology at GSK, Director of Regulatory Affairs at Vertex Pharmaceuticals, and Senior Associate Director at Novartis. Visiers Guelbenzu's foundational experience includes roles at Millennium Pharmaceuticals, Mount Sinai Medical Center, and a robust academic background with a PhD in Medicinal Chemistry from the University of Navarra and a Post Doctorate in Biophysics focused on GPCR modeling from the Icahn School of Medicine at Mount Sinai.